Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1965 4
1966 5
1967 4
1968 4
1969 1
1970 3
1971 2
1972 2
1973 3
1974 1
1975 1
1976 2
1977 7
1978 3
1979 4
1980 1
1982 1
1983 1
1984 1
1985 3
1986 6
1987 4
1988 3
1989 1
1991 1
1992 2
1993 2
1995 3
1996 3
1998 2
1999 2
2000 1
2002 4
2003 4
2004 4
2005 3
2006 5
2007 1
2008 3
2009 7
2010 4
2011 4
2012 5
2013 4
2014 11
2015 6
2016 2
2017 4
2018 2
2020 7
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.
Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN; International Urogynecological Association; International Continence Society. Haylen BT, et al. Among authors: freeman rm. Neurourol Urodyn. 2010;29(1):4-20. doi: 10.1002/nau.20798. Neurourol Urodyn. 2010. PMID: 19941278 Review.
Overactive bladder.
Freeman RM, Adekanmi OA. Freeman RM, et al. Best Pract Res Clin Obstet Gynaecol. 2005 Dec;19(6):829-41. doi: 10.1016/j.bpobgyn.2005.08.002. Epub 2005 Sep 19. Best Pract Res Clin Obstet Gynaecol. 2005. PMID: 16176887 Review.
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.
Sternberg CN, Skoneczna I, Kerst JM, Albers P, Fossa SD, Agerbaek M, Dumez H, de Santis M, Théodore C, Leahy MG, Chester JD, Verbaeys A, Daugaard G, Wood L, Witjes JA, de Wit R, Geoffrois L, Sengelov L, Thalmann G, Charpentier D, Rolland F, Mignot L, Sundar S, Symonds P, Graham J, Joly F, Marreaud S, Collette L, Sylvester R; European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group; Groupe d'Etude des Tumeurs Urogénitales; National Cancer Research Institute Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; German Association of Urologic Oncology. Sternberg CN, et al. Lancet Oncol. 2015 Jan;16(1):76-86. doi: 10.1016/S1470-2045(14)71160-X. Epub 2014 Dec 11. Lancet Oncol. 2015. PMID: 25498218 Free article. Clinical Trial.
The great mesh debate.
Freeman RM, Lose G. Freeman RM, et al. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Aug;20(8):889-91. doi: 10.1007/s00192-009-0927-5. Epub 2009 Jun 10. Int Urogynecol J Pelvic Floor Dysfunct. 2009. PMID: 19513573 No abstract available.
Hard-water syndrome.
Freeman RM, Lawton RL, Chamberlain MA. Freeman RM, et al. N Engl J Med. 1967 May 18;276(20):1113-8. doi: 10.1056/NEJM196705182762003. N Engl J Med. 1967. PMID: 6024165 No abstract available.
155 results